Pharmacy
News
Adjunct T-cell therapy granted orphan designation
The designation is for the combination of BPX-501 genetically modified T cells and the activator agent rimiducid as replacement T-cell therapy for...
News
Antiplatelet agent approved for long-term use
Photo courtesy of the CDC The European Commission has approved use of the antiplatelet agent ticagrelor (Brilique) at a 60 mg dose to treat...
News
Product approved to treat hemophilia A in EU
The European Commission has approved a full-length recombinant factor VIII product for the treatment and prevention of bleeding in hemophilia A...
News
Drug granted breakthrough designation for AML
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for midostaurin (PKC412) to treat acute myeloid leukemia (...
News
Health Canada approves ruxolitinib for PV
Image courtesy of AFIP Health Canada has approved the JAK1/2 inhibitor ruxolitinib (Jakavi) for the control of hematocrit in adult patients with...
News
Development of myelofibrosis drug on hold
The US Food and Drug Administration (FDA) has placed a full clinical hold on trials conducted under the investigational new drug application for...
News
MF drug trials placed on partial clinical hold
The US Food and Drug Administration (FDA) has placed a partial clinical hold on trials conducted under the investigational new drug (IND)...
News
EMA recommends therapy for bleeding disorder
The European Medicines Agency (EMA) has recommended marketing authorization for Coagadex to treat hereditary factor X deficiency, a rare bleeding...
News
Rivaroxaban trial results hold up, EMA says
The European Medicines Agency (EMA) has concluded that a defect discovered in a system used to measure international normalized ratios (INRs) in...
News
FDA approves drug for patients receiving MEC
Photo by Rhoda Baer The US Food and Drug Administration (FDA) has approved a supplemental new drug application for single-dose fosaprepitant...
News
Generic imatinib launched with savings program
Photo by Rhoda Baer Sun Pharma has announced the US launch of imatinib mesylate tablets, which are a generic version of Novartis’s Gleevec, for...